Relationship of TIMI Myocardial Perfusion Grade to Mortality After Administration of Thrombolytic Drugs
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Background —Although improved epicardial blood flow (as assessed with either TIMI flow grades or TIMI frame count) has been related to reduced mortality after administration of thrombolytic drugs, the relationship of myocardial perfusion (as assessed on the coronary arteriogram) to mortality has not been examined. Methods and Results —A new, simple angiographic method, the TIMI myocardial perfusion (TMP) grade, was used to assess the filling and clearance of contrast in the myocardium in 762 patients in the TIMI (Thrombolysis In Myocardial Infarction) 10B trial, and its relationship to mortality was examined. TMP grade 0 was defined as no apparent tissue-level perfusion (no ground-glass appearance of blush or opacification of the myocardium) in the distribution of the culprit artery; TMP grade 1 indicates presence of myocardial blush but no clearance from the microvasculature (blush or a stain was present on the next injection); TMP grade 2 blush clears slowly (blush is strongly persistent and diminishes minimally or not at all during 3 cardiac cycles of the washout phase); and TMP grade 3 indicates that blush begins to clear during washout (blush is minimally persistent after 3 cardiac cycles of washout). There was a mortality gradient across the TMP grades, with mortality lowest in those patients with TMP grade 3 (2.0%), intermediate in TMP grade 2 (4.4%), and highest in TMP grades 0 and 1 (6.0%; 3-way P =0.05). Even among patients with TIMI grade 3 flow in the epicardial artery, the TMP grades allowed further risk stratification of 30-day mortality: 0.73% for TMP grade 3; 2.9% for TMP grade 2; 5.0% for TMP grade 0 or 1 ( P =0.03 for TMP grade 3 versus grades 0, 1, and 2; 3-way P =0.066). TMP grade 3 flow was a multivariate correlate of 30-day mortality (OR 0.35, 95% CI 0.12 to 1.02, P =0.054) in a multivariate model that adjusted for the presence of TIMI 3 flow ( P =NS), the corrected TIMI frame count (OR 1.02, P =0.06), the presence of an anterior myocardial infarction (OR 2.3, P =0.03), pulse rate on admission ( P =NS), female sex ( P =NS), and age (OR 1.1, P <0.001). Conclusions —Impaired perfusion of the myocardium on coronary arteriography by use of the TMP grade is related to a higher risk of mortality after administration of thrombolytic drugs that is independent of flow in the epicardial artery. Patients with both normal epicardial flow (TIMI grade 3 flow) and normal tissue level perfusion (TMP grade 3) have an extremely low risk of mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings
The TIMI Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121437 · Cited by 3,188
TIMI Frame Count: A Quantitative Method of Assessing Coronary Artery Flow
Gibson, C. M., Cannon, C. P., Daley, W. L., Dodge, J. T., Alexander, B., Marble, S. J., McCabe, C. H., Raymond, L., Fortin, T., Poole, W. K., et al. (1996) · Circulation · doi:10.1161/01.cir.93.5.879 · Cited by 1,866
Self-citation(1993) · New England Journal of Medicine · doi:10.1056/nejm199311253292204 · Cited by 1,866
The Thrombolysis in Myocardial Infarction (TIMI) Trial
(1985) · New England Journal of Medicine · doi:10.1056/nejm198510173131611 · Cited by 1,319
van ‘t Hof, A. W. J., Liem, A., Suryapranata, H., Hoorntje, J. C. A., de Boer, M.-J., & Zijlstra, F. (1998) · Circulation · doi:10.1161/01.cir.97.23.2302 · Cited by 1,307
Ito, H., Tomooka, T., Sakai, N., Yu, H., Higashino, Y., Fujii, K., Masuyama, T., Kitabatake, A., & Minamino, T. (1992) · Circulation · doi:10.1161/01.cir.85.5.1699 · Cited by 1,054
Relationship Between TIMI Frame Count and Clinical Outcomes After Thrombolytic Administration
Gibson, C. M., Murphy, S. A., Rizzo, M. J., Ryan, K. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Van de Werf, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.99.15.1945 · Cited by 415
Self-citationCannon, C. P., Gibson, C. M., McCabe, C. H., Adgey, A. A. J., Schweiger, M. J., Sequeira, R. F., Grollier, G., Giugliano, R. P., Frey, M., Mueller, H. S., et al. (1998) · Circulation · doi:10.1161/01.cir.98.25.2805 · Cited by 354
Self-citationVogt, A., von Essen, R., Tebbe, U., Feuerer, W., Appel, K.-F., & Neuhaus, K.-L. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90314-q · Cited by 265
Karagounis, L., Sorensen, S. G., Menlove, R. L., Moreno, F., & Anderson, J. L. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90043-m · Cited by 238
Maes, A., Van de Werf, F., Nuyts, J., Bormans, G., Desmet, W., & Mortelmans, L. (1995) · Circulation · doi:10.1161/01.cir.92.8.2072 · Cited by 168
Self-citationDISCREPANCIES BETWEEN THE EFFECTS OF CORONARY REPERFUSION ON SURVIVAL AND LEFT VENTRICULAR FUNCTION
de Werf, F. V. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92812-2 · Cited by 152
Kenner, M. D., Zajac, E. J., Kondos, G. T., Dave, R. H., Winkelmann, J. W., Joftus, J., Laucevičius, A., Kybarskis, A., Berūkštis, E., Urbonas, A., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80250-1 · Cited by 134
Cited by
Sabatine, M. S., Cannon, C. P., Gibson, C. M., López-Sendón, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050522 · Cited by 1,924
Self-citationCoronary Microvascular Dysfunction
Camici, P. G., & Crea, F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra061889 · Cited by 1,605
Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., Gerstenblith, G., DeMaria, A. N., Denktas, A. E., Gammon, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.055 · Cited by 1,350
Coronary Microvascular Dysfunction
Crea, F., Lanza, G. A., & Camici, P. G. (2014) · Springer eBooks · doi:10.1007/978-88-470-5367-0 · Cited by 1,287
Novel Index for Invasively Assessing the Coronary Microcirculation
Fearon, W. F., Balsam, L. B., Farouque, H. M. O., Robbins, R. C., Fitzgerald, P. J., Yock, P. G., & Yeung, A. C. (2003) · Circulation · doi:10.1161/01.cir.0000080700.98607.d1 · Cited by 681
Metadata
- Authors
- Gibson, C. M., Cannon, C. P., Murphy, S. A., Ryan, K. A., Mesley, R., Marble, S. J., McCabe, C. H., Van de Werf, F., & Braunwald, E.
- Venue
- Circulation
- Published
- 2000-01-18
- Volume
- 101
- Issue
- 2
- Pages
- 125-130
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2087165431
- Cited by
- 858
- References
- 13
- FWCI
- 31.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.